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Background and aims: Atherogenesis involves a complex interaction between immune cells and lipids, processes 
greatly influenced by the vascular smooth muscle cell (VSMC) phenotype. The DNA glycosylase NEIL3 has 
previously been shown to have a role in atherogenesis, though whether this is due to its ability to repair DNA 
damage or to other non-canonical functions is not yet clear. Hereby, we investigate the role of NEIL3 in 
atherogenesis, specifically in VSMC phenotypic modulation, which is critical in plaque formation and stability. 
Methods: Chow diet-fed atherosclerosis-prone Apoe− /− mice deficient in Neil3, and NEIL3-abrogated human 
primary aortic VSMCs were characterized by qPCR, and immunohistochemical and enzymatic-based assays; 
moreover, single-cell RNA sequencing, mRNA sequencing, and proteomics were used to map the molecular ef-
fects of Neil3/NEIL3 deficiency in the aortic VSMC phenotype. Furthermore, BrdU-based proliferation assays and 
Western blot were performed to elucidate the involvement of the Akt signaling pathway in the trans-
differentiation of aortic VSMCs lacking Neil3/NEIL3. 
Results: We show that Neil3 deficiency increases atherosclerotic plaque development without affecting systemic 
lipids. This observation was associated with a shift in VSMC phenotype towards a proliferating, lipid- 
accumulating and secretory macrophage-like cell phenotype, without changes in DNA damage. VSMC 
* Corresponding author. Research Institute of Internal Medicine, Oslo University Hospital Rikshospitalet, Sognsvannsveien 20, 0372, Oslo, Norway. 
E-mail address: Bente.Halvorsen@rr-research.no (B. Halvorsen).   
1 The authors share first co-authorship. 
Contents lists available at ScienceDirect 
Atherosclerosis 
journal homepage: www.elsevier.com/locate/atherosclerosis 
https://doi.org/10.1016/j.atherosclerosis.2021.02.023 
Received 24 July 2020; Received in revised form 12 February 2021; Accepted 19 February 2021   
Atherosclerosis xxx (xxxx) xxx
2
transdifferentiation in Neil3-deficient mice encompassed increased activity of the Akt signaling pathway, sup-
ported by cell experiments showing Akt-dependent proliferation in NEIL3-abrogated human primary aortic 
VSMCs. 
Conclusions: Our findings show that Neil3 deficiency promotes atherosclerosis development through non- 
canonical mechanisms affecting VSMC phenotype involving activation of the Akt signaling pathway.   
1. Introduction 
Despite great improvement in the treatment of heart and stroke 
disease, atherosclerosis remains the leading cause of death and loss of 
productive life years worldwide [1]. Common risk factors such as 
smoking, hyperlipidemia and obesity [2] trigger sustained injury to both 
circulating and vascular cells that not only initiate but also accelerate 
the atherogenic process, with inflammation and immune activation as 
common mediators. Classical immune cells are of major importance in 
this process, but also vascular smooth muscle cells (VSMCs) have crucial 
anti- and pro-atherogenic functions. Thus, whereas VSMCs can induce 
plaque stabilization by collagen production, resulting in the formation 
of a fibrous cap [3], their remarkable plasticity can also induce a plaque 
destabilization phenotype in this cells by promoting secretion of 
matrix-degrading enzymes [4]. VSMC phenotypic switch is therefore an 
important event in the development and fate of atherosclerotic plaques, 
and factors regulating this process are important to identify to better 
understand the complex molecular mechanisms underlying atherogen-
esis, and thereby uncover new targets for therapy in atherosclerotic 
disorders. 
Increased oxidative stress is a hallmark feature of atherosclerotic 
plaques and results in the production of reactive oxygen species (ROS) 
that induce nuclear and mitochondrial DNA damage. VSMCs within 
human atherosclerotic plaques have been shown to harbor increased 
DNA damage which, if left unresolved, could lead to cellular injury and 
apoptosis promoting plaque instability [5,6]. The base-excision repair 
(BER) pathway is the main repair mechanism for oxidation-induced 
DNA damage, initiated by lesion-specific DNA glycosylases which 
remove the damaged base [7]. Recent studies, however, suggest that 
some DNA glycosylases (e.g., NEIL3) may have functions beyond ca-
nonical DNA repair. We have recently reported increased proliferation 
of myofibroblasts in ruptured hearts in a Neil3-deficient myocardial 
infarction (MI)-mouse model [8], and NEIL3 expression profile is 
upregulated in early S phase in several human cell lines, supporting a 
role for NEIL3 in the regulation of cell cycle and proliferation [9]. We 
have also shown that a genetic variant of human NEIL3 is associated 
with increased risk of MI [10], suggesting that NEIL3 is important in the 
development of atherosclerotic disease. Moreover, we have previously 
showed that Neil3 deficiency increased susceptibility to develop 
atherosclerosis in Apoe− /− mice fed a high fat diet involving altered 
function of macrophages [11]. The role of NEIL3 in the regulation of 
VSMC proliferation is, however, not known. In the present study, we 
elucidated the function of Neil3 in the development of atherosclerosis 
and explored the role of Neil3/NEIL3 in VSMC proliferation and 
phenotypic switch in Apoe− /− /Neil3− /− mice exposed to a chow diet. 
2. Materials and methods 
For an extended version of Materials and Methods, please see the 
Supplementary Materials. 
2.1. Mice 
Neil3-deficient mice were generated by germline deletion of exons 3- 
5 as previously described [12], and backcrossed into C57BL/6J mice for 
10 generations. Apoe− /− /Neil3− /− mice were generated by crossing 
Neil3− /− mice with Apoe− /− (C57BL/6J background) mice, obtained 
from Taconic (Denmark) for 3 generations. The Apoe− /− mice used as 
controls in the study were bred out from the Apoe− /− /Neil3− /− line. All 
mice included in the study were born at the Centre for Comparative 
Medicine, Oslo University Hospital Rikshospitalet, in Oslo (Norway). 
Genotyping of Apoe− /− and Apoe− /− /Neil3− /− mice was carried out by 
use of the HotSHOT method for DNA preparation. DNA was mixed with 
specific primers (primer sequences can be provided upon request), PCR 
MasterMix (Promega, Madison, WI) and H2O and amplified using the 
GeneAmp 9700 PCR System (Applied Biosystems, CA). Mice were fed a 
chow standard diet (RM3-P product code 801700) from Special Diets 
Services (www.sdsdiets.com) ad libitum until harvest at 26 weeks of age. 
All murine studies were conducted in accordance with the regulations 
on the use of experimental animals established by the Norwegian 
governmental agency “Mattilsynet” (The Norwegian Food Safety Au-
thority), with “Forsøksdyrutvalgets tilsyn-og søknadssystem” (FOTS) 
application numbers 5263 and 8648. 
2.2. Generation of NEIL3 knock-down primary human aortic smooth 
muscle cells and cell experiments 
For in vitro experiments, we designed synthetic single-stranded RNA- 
DNA hybrid antisense oligonucleotides (GapmeRs) for post- 
transcriptional silencing of NEIL3 messenger RNA (mRNA), as 
described elsewhere [13]. NEIL3 GapmeRs were designed towards exon 
4 of NEIL3 (NEIL3 KD) with sequence 5′-CUUAUUCTCTGTTGG 
CUUUCCA-3′, and a scrambled GapmeR (Control) used as control, with 
sequence 5′-UAUAUCCGGTTCTTTCUUGCUC-3’ (Eurogentec, Liége, 
Belgium). Primary human aortic smooth muscle cells (HaoVSMCs; 
PromoCell GmbH, Heidelberg, Germany) were grown in PromoCell 
Growth Medium (PromoCell GmbH, Heidelberg, Germany) and 1% 
penicillin streptomycin at 37 ◦C with 5% CO2. HaoVSMCs were treated 
with 0.5 μM NEIL3 GapmeRs for 48 h, and used for subsequent experi-
ments on VSMC function. GapmeR-treated HaoVSMCs proliferation was 
assessed by means of the chemiluminescent immunoassay Cell Prolif-
eration ELISA, BrdU (Roche Applied Science, Germany), based on the 
measurement of BrdU incorporation during DNA synthesis in replicating 
cells according to manufacturer’s guidelines. The chemiluminescent 
signal was quantified by measuring the photons using a microplate 
luminometer with photomultiplier technology. These relative light units 
per second (rlu/s) directly correlate to the amount of DNA synthesis, 
hence to the number of proliferating cells in the corresponding cell 
microculture. For the cellular lipid-staining, HaoVSMCs were cultured 
as described previously, and plated out at a cell density of 2-5x104 
cells/well in a cell culture plate, 24-well, polystyrene, Cell+ growth 
surface for sensitive adherent cells (Sarstedt, Oslo, Norway). NEIL3 gene 
expression was knocked down using 0.5 μM GapmeRs supplied to the 
cellular medium. Cells without GapmeRs and with the scrambled control 
(0.5 μM) were used as control conditions. After 48 h pre-incubation with 
GapmeR solution, Dil-labeled medium oxLDL (1 μg/mL; Kalen 
Biomedical) was added to the culture medium. After 24 h of lipid 
loading, cells were extensively washed with 2x PBS to remove 
unspecific-bound OxLDL, and fixated using 4% PFA (Histolab). Cells 
were counterstained and embedded using a SlowFade Gold Antifade 
mountant containing DAPI nuclear stain (ThermoFisher) or Hoescht 
33258 (ThermoScientific) for nuclear staining. Images were captured by 
use of a Nikon DS Fi1 camera on a Nikon Eclipse E400 microscope. 
Furthermore, scramble- and NEIL3 GapmeR-treated HaoVSMCs were 
incubated with 20 μg/mL oxLDL for 24 h. Cells were washed in ice-cold 
PBS and fixated in formaldehyde (2% in PBS) for 30 min at room 
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temperature. Neutral lipids were extracted twice in hexane-isopropanol 
3:2 (v/v). The solvent was pooled from each extraction and evaporated 
under N2, and finally solubilized in isopropanol before total cholesterol 
and triacylglycerol levels were analyzed (using same assays as described 
for murine serum samples). For experiments on the role of AKT signaling 
in HaoVSMCs, NEIL3 GampeR-treated HaoVSMCs were incubated for 6 
h before addition of 10 μM AKT 1/2 inhibitor (Tocris, Biotechne, Min-
neapolis, MN) and incubated further for 18 h before harvest. 
2.3. Gene expression analyses of murine whole aorta and aortic VSMCs, 
and HaoVSMCs 
Total RNA was isolated from murine whole aorta and aortic VSMCs, 
and HaoVSMCs using RNeasy spin columns (Qiagen, Germany). The 
RNA was treated with DNase (Qiagen) and stored at − 80 ◦C until 
analysis. RNA concentrations and purity were assessed by spectropho-
tometer absorbance (NanoDrop ND-1000 Thermo Scientific, Wilming-
ton, DE). Synthesis of cDNA was performed using q-Script cDNA 
Synthesis kit (Quanta Bioscience, Gaithersburg, MD). Real-time mRNA 
quantification was performed using Perfecta SYBRGreen Fastmix ROX 
(Quanta Bioscience, Gaithersburg, MD) and the 9700HT Fast Real-Time 
PCR System with the proprietary SDS 2.4 software (Applied Biosystems). 
The RT-qPCR program was set as specified by the supplier. All primer 
sequences can be provided upon request. For each transcript, RT-qPCR 
was conducted in duplicates, and target transcript levels were quanti-
fied by the comparative Ct method using mouse or human β-ACTIN or 
GAPDH as endogenous control. AKT1 mRNA was detected by using 
TaqMan assay primers and probes mix (HS00178289_m1 human AKT1, 
and Mm01331626_m1 Mouse Akt1; Applied Biosystems, USA). Total 
RNA was also used for mRNA-seq of both murine VSMCs (n = 2-3) and 
human HaoVSMCs (n = 2-3) performed by Novogene Co., Ltd (China). 
mRNA-seq raw files were trimmed with fastp (v0.20.0) [14] in 
paired-end mode with default setting to remove adapters and low 
quality reads. Filtered reads were mapped to mouse cDNA (GRCm38.p6, 
NCBI Mus musculus Annotation Release 108) and human cDNA 
(GRCh38.p13, NCBI Homo sapiens Updated Annotation Release 
109.20190905) respectively [15] using Kallisto (v0.46.0) with 100 
bootstrap iterations [16]. Sleuth (v0.30.0) was used to obtain deferen-
tially expressed transcripts with Wald test, with beta values being the 
effect size on the natural-log transformed data, an estimator of the fold 
change [17]. Both RNA-seqs have been deposited in the NCBI GEO re-
pository [18], with project number GSE140791. Pathway and Process 
enrichment of Gene Ontology Biological Processes analyses were per-
formed using Metascape using default settings [19]. To assess expression 
of Neil3 in individual cells, we analyzed single-cell RNA sequencing 
(scRNA-seq) data from healthy whole aorta and lineage-traced VSMCs in 
plaques of Apoe− /− mice as previously described [20]. 
2.4. Label-free quantitative proteome analysis 
Four biological replicates were used for total proteome analysis of 
human aortic VSMCs. Cells were treated with NEIL3 GapmeR (GM), 
scrambled GapmeR (SRC) or left untreated (Ctrl). Cell pellets were lysed 
with ProteaseMAX™ Surfactant (Promega), and proteins were reduced, 
alkylated and digested into peptides with trypsin (Promega). The 
resulting peptides were desalted and concentrated before mass spec-
trometry by the STAGE-TIP method using a C18 resin disk (3 M Empore). 
Each peptide mixture was analyzed by a nEASY-LC coupled to QExactive 
(Thermo Electron, Bremen, Germany) with EASY Spray PepMap® RSLC 
column (C18, 2 μl, 100 Å, 75 μm × 250 mm) using 120 min LC sepa-
ration gradient. The resulting MS raw files were submitted to the Max-
Quant software version 1.6.1.0 for protein identification and label-free 
quantification (LFQ). Carbamidomethyl (C) was set as a fixed modifi-
cation and acetyl (protein N-term), carbamyl (N-term) and oxidation 
(M) were set as variable modifications. First search peptide tolerance of 
20 ppm and main search error 4.5 ppm were used. Trypsin without 
proline restriction enzyme option was used, with two allowed mis-
cleavages. The minimal unique + razor peptides number was set to 1, 
and the allowed FDR was 0.01 (1%) for peptide and protein identifica-
tion. Label-free quantitation was employed with default settings. The 
UniProt database with ‘human’ entries (October 2017) was used for the 
database searches. Known contaminants as provided by MaxQuant and 
identified in the samples were excluded from further analysis. For 
pathway analysis, Reactome v75 database using gene set analysis 
PADOG (Pathway Analysis with Down-weighting of Overlapping Genes) 
algorithm was performed. The mass spectrometry proteomics data have 
been deposited to the ProteomeXchange Consortium via the PRIDE 
partner repository [21], with dataset identifier PXD016345. 
2.5. Western immunoblots of murine aorta and VSMCs 
Total protein was extracted from ex vivo aortic VSMC outgrowth, 
whole murine aortas and NEIL3-abrogated HaoVSMCs by M-PER™ 
Mammalian Protein Extraction Reagent or T-PER™ Tissue Protein 
Extraction Reagent containing Halt™ Protease and Phosphatase Inhib-
itor, and protein concentrations were determined by Pierce™ BCA 
Protein Assay Kit (all from Thermo Fisher Scientific). Proteins were 
separated by SDS-PAGE and transferred to a PVDF membrane. The 
following antibodies were used against: Tagln (ab14106, Abcam), 
Myocd (MAB4028, R&D systems), Akt (9272, Cell Signaling), Phospho- 
Akt (Thr308; 9275, Cell Signaling), GAPDH (sc-365062, Santa Cruz 
Biotechnology), β-Actin (A5441, Sigma-Aldrich), Anti-rabbit IgG (7074, 
Cell Signaling) and Anti-mouse IgG (7076, Cell Signaling). The mem-
branes were developed with Radiance Plus Substrate (Azure Bio-
systems), and images captured by LAS-4000 (Fujifilm) and quantified by 
Image Studio Lite (Ver 5.2, Li-Cor, Lincoln, NE). 
2.6. Statistics 
All data were analyzed using parametric, i.e., t-test, and non- 
parametric tests, i.e., Mann-Whitney U test, or 2-way ANOVA (with 
Sidak’s test) for grouped data. Data are presented as mean and standard 
deviation (SD) unless otherwise stated. Statistical analyses for signifi-
cance were performed using GraphPad Prism 8 (La Jolla, CA) and p- 
values <0.05 were considered statistically significant. The same soft-
ware performed identification of statistical outliers using Grubb’s test 
with α = 0.05. For Gene Ontology analyses input gene list from both 
murine VSMCs and HaoVSMCs p-value cutoff was set to ≤0.001. For 
proteomics, Perseus 1.6.1.3 was used for the statistical analysis of the 
total proteome MaxQuant results, with p < 0.05 as cut-off. 
3. Results 
3.1. Increased atherosclerosis in Apoe− /− /Neil3− /− mice 
Atherosclerosis was quantified by Oil Red O (ORO) staining in aortic 
roots of Apoe− /− and Apoe− /− /Neil3− /− mice on chow diet at 26 weeks of 
age, showing significantly increased atherosclerotic lesion area in the 
aortic root of Apoe− /− /Neil3− /− mice, as compared to Apoe− /− mice 
(Fig. 1A and B). En face plaque quantification analysis with Sudan IV 
staining, however, revealed no significant differences in aortic arch le-
sions when comparing Apoe− /− and Apoe− /− /Neil3− /− mice (Supple-
mentary Fig.1). Immunohistochemical staining of the aortic root using 
traditional cell markers showed no significant differences in total plaque 
composition between genotypes when analyzing macrophages (Cd68+), 
endothelial cells (Vcam1+), VSMCs (Acta2+), T cells (Cd4+ and Cd8+), 
or collagen composition (Sirius Red+) (Supplementary Fig. 2 and 3). 
3.2. Neil3 deficiency had no effects on circulating lipids or blood pressure 
in Apoe− /− mice fed a chow diet 
Surprisingly, the increased plaque area in the aortic root of Apoe− / 
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− /Neil3− /− mice was not accompanied by changes in serum total 
cholesterol, oxidized LDL, nor triglyceride levels as compared to Apoe− / 
− mice (Supplementary Fig. 4). Further, there were no differences in 
blood pressure between Apoe− /− and Apoe− /− /Neil3− /− mice (Supple-
mentary Fig. 5). In addition, analysis of the cytokine profile in murine 
plasma presented only modest changes, with decreased levels of both 
pro- (i.e., Interleukin (IL)-1β, Csf3, and IL-12p40) and anti-atherogenic 
(i.e., IL-5) cytokines in Apoe− /− /Neil3− /− mice (Table 1 Supplemen-
tary Materials). 
3.3. Increased medial VSMC layer area and disorganization in aortic 
roots of Apoe− /− /Neil3− /− mice 
Despite no changes in typical cell markers of plaque composition, 
ORO-stained murine aortic root specimens revealed significantly 
increased media layer thickness and increased percentage of media area 
to total aortic lesion area in Apoe− /− /Neil3− /− compared to Apoe− /−
mice (Fig. 1C). Interestingly, the same sections showed an increased 
level of VSMC disorganization inside the media layer of the aorta in 
Apoe− /− /Neil3− /− mice compared to Apoe− /− controls (Fig. 1D). 
Increased media layer thickness, accompanied by VSMC layer disorga-
nization in Apoe− /− /Neil3− /− mice, point towards a role of VSMCs in our 
model. 
3.4. Increased VSMC proliferation and phenotypic changes in aortas of 
Apoe− /− /Neil3− /− mice 
Based on these findings, we further assessed VSMC proliferation in 
an ex vivo explant assay of Apoe− /− and Apoe− /− /Neil3− /− aortas. Both 
measurement of ex vivo aortic VSMC outgrowth and cell count from 
aortic arch sections showed increased proliferation of aortic VSMCs in 
Apoe− /− /Neil3− /− mice compared to Apoe− /− (Fig. 1E). Immunofluo-
rescent staining on VSMCs from aortic explants with proliferating cell 
nuclear antigen (PCNA), an established marker of cell proliferation, 
identified increased Pcna+ VSMCs in aortic explants from Apoe− / 
− /Neil3− /− specimens compared to Apoe− /− controls (Fig. 1F). Inspec-
tion of ORO-stained sections of murine aortic roots revealed lipid 
accumulation inside medial aortic VSMCs in Apoe− /− /Neil3− /−
(Fig. 1G). In addition, mRNA expression (Fig. 1H) and protein levels 
(Fig. 1J) of VSMC differentiation markers transgelin (Tagln, SM22α) and 
myocardin (Myocd) [22] were decreased in Apoe− /− /Neil3− /− aortas, 
indicating cell de-differentiation. These results point towards pheno-
typic modulation of VSMCs, presenting a proliferating, 
de-differentiated, and lipid-accumulating phenotype in Apoe-deficient 
mice lacking Neil3. 
3.5. Neil3 is expressed in a subset of murine VSMCs in Apoe-deficient 
mice 
To further examine the role of Neil3 in the regulation of VSMCs, we 
analyzed single cell-RNA sequencing (scRNA-seq) datasets generated 
from arteries of Apoe-deficient mice [20]. Though only in a small per-
centage of cells, Neil3 expression was present in some VSMCs in plaques, 
which interestingly mostly fell within the expression domain of the 
progenitor cell marker Ly6/Sca-1, which is upregulated in VSMCs within 
lesions (Supplementary Fig. 6A and B). In contrast, Neil3 was not found 
in any lineage of VSMCs in healthy vessels (Supplementary Fig. 6C and 
D). These data further support a link between Neil3 and VSMC 
proliferation. 
3.6. NEIL3 deficiency induces increased proliferation, phenotypic 
transdifferentiation and lipid uptake in primary human aortic VSMCs 
Our findings so far suggest that increased atherosclerosis in Apoe− / 
− /Neil3− /− mice could be due to a modulation in VSMC phenotype with 
increased cell proliferation and lipid uptake. To further elucidate the 
effect of Neil3 deficiency on VSMC phenotype, we established an in vitro 
model in which NEIL3 expression was abrogated in primary human 
aortic VSMCs (HaoVSMC) by means of post-transcriptional gene 
silencing. Expression of NEIL3 in HaoVSMCs was significantly reduced 
(>70%) after NEIL3 GapmeR treatment for 18 h (Supplementary Fig. 7), 
and NEIL3-deficient HaoVSMCs demonstrated significantly increased 
proliferation compared to controls (Fig. 2). VSMC transdifferentiation to 
a more macrophage- or chondrocyte-like cell phenotype has been pre-
viously described to promote atherosclerosis [20,23], and notably the 
NEIL3-deficient HaoVSMCs showed increased mRNA levels of markers 
associated with both proliferation and phenotypic switching i.e., CD68, 
TGF-β, PAI-1, and matrix metalloproteinase (MMP)-2 (Fig. 2B). 
Conversely, ACTA2, a canonical VSMC marker, did not show differences 
between NEIL3 abrogated-HaoVSMCs and controls. Also, NEIL3 
KD-HaoVSMC displayed increased secretion of MMP-2, a major player in 
plaque progression and destabilization (Fig. 2C) [24], as well as 
increased lipid uptake compared to controls (Fig. 2D-F), suggesting a 
phenotypic shift also at the functional level. Taken together, these 
findings indicate that NEIL3 deficiency drives VSMCs towards a more 
macrophage-like cell phenotype, which could contribute to atheroscle-
rotic plaque progression. 
3.7. Unaltered genome integrity in Apoe− /− /Neil3− /− mice 
Since Neil3 is a DNA repair enzyme removing oxidation-induced 
DNA base lesions as part of the BER pathway, we investigated 
whether the aforementioned observations were a result of attenuated 
DNA repair capacity in Apoe− /− /Neil3− /− mice. After measuring accu-
mulation of damage in genomic DNA, we did not find differences in 
neither nuclear nor mitochondrial DNA integrity of murine aortic 
VSMCs when comparing the two genotypes (Supplementary Fig. 8A). 
The bulk level of the major oxidized DNA base lesion 8-oxoG displayed 
was further similar in the nuclear genome of Apoe− /− /Neil3− /− and 
Apoe− /− livers (Supplementary Fig. 8B). These results demonstrate that 
the effect of Neil3 on atherogenesis is probably not directly related to 
DNA repair deficiency. 
3.8. Transcriptomic and proteomic analyses confirm phenotypic 
modulation in both murine and human aortic Neil3/NEIL3-deficient 
VSMCs 
To further explore the NEIL3-related mechanisms underlying this 
Fig. 1. Neil3 deficiency increases atherosclerosis with increased medial VSMC thickness and proliferation in Apoe-deficient mice. 
(A) Representative cryosections (10 μm) of aortic roots stained with Oil Red O (ORO) and hematoxylin (original magnification 40x). (B) Atherosclerosis quantifi-
cation as mean and SEM of relative lesion areas at 8 different consecutive points in the aortic root of Apoe− /− (n = 8-10) and Apoe− /− /Neil3− /− (n = 8-9) mice. *p <
0.05 versus Apoe− /− mice (2-way ANOVA with Sidak’s test). (C) Quantitative assessment of the vascular wall as medial wall thickness and percentage medial to total 
lesion area in Apoe− /− /Neil3− /− mice. Media thickness measurements are an average of ≥5 measurements at different locations/valve/mouse; i.e. ≥ 15 measure-
ments/mouse. (D) Representative pictures of ORO-stained aortic roots of Apoe− /− and Apoe− /− /Neil3− /− mice. Magnification boxes show a representative region of 
interest within the aortic root, emphasizing disrupted VSMC multilayer organization in Apoe− /− /Neil3− /− as compared to Apoe− /− mice. (E) VSMC outgrowth 
percentage and cell count from aortic explants of Apoe− /− and Apoe− /− /Neil3− /− mice (n = 4-8). (F) Representative pictures of DAPI/PCNA co-immunostaining and 
quantification in aortic VSMC from outgrowth explants of Apoe− /− and Apoe− /− /Neil3− /− mice. (G) Representative picture of ORO-staining accumulated in the 
medial VSMC layer. Tagln and Myocd mRNA expression (H) and protein (J) levels in thoracic aortic tissue from Apoe− /− and Apoe− /− /Neil3− /− mice (n = 3-17). Data 
presented as mean and SD. T-test *p < 0.05, **p < 0.01. 
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VSMC phenotype we performed different sequencing analyses. mRNA- 
seq revealed that aortic VSMCs from Apoe− /− /Neil3− /− mice were 
enriched in genes involved in cell proliferation and development (i.e., 
GO biological processes included extracellular structure organization/ 
adhesion, mitochondrial outer layer membrane permeabilization/ 
apoptosis, differentiation and morphogenesis, responses to growth fac-
tors and cytokines) compared to Apoe− /− mice (Fig. 3A and Supple-
mentary Table 2). Similarly, mRNA-seq of NEIL3-deficient HaoVSMCs 
revealed enrichment in genes associated with cell adhesion, prolifera-
tion/apoptosis, and response to growth factors, morphogenesis, differ-
entiation, and development (Fig. 4A and Supplementary Table 3). 
Phenotypic modulation in NEIL3-deficient HaoVSMCs was further 
confirmed using label-free quantitative proteomics. Out of 139 signifi-
cantly regulated proteins, we found 29 proteins associated with cell 
proliferation, migration, morphology, and structural organization 
(Fig. 4C and Supplementary Table 4). 
3.9. Lack of Neil3/NEIL3 affects VSMC proliferation and lipid uptake 
through the Akt signaling pathway 
The Akt signaling pathway has been extensively linked to VSMC 
proliferation and phenotypic switching [25,26]. Although it was not of 
the most up-regulated genes in NEIL3-abrogated HaoVSMC mRNA-seq, a 
more in-depth examination of the HaoVSMC proteomics by PADOG 
Reactome analysis showed that the top differentially upregulated 
pathway in HaoVSMCs lacking NEIL3 is “NF-κB activated and signals 
survival” (Supplementary Table 5), which has been shown to be a 
downstream target of the Akt signaling pathway promoting cell survival 
[27]. Importantly, murine Akt was one of the gene hits regulating most 
pathways in the mRNA-seq analysis in aortic VSMCs from 
Apoe− /− /Neil3− /− mice as compared to Apoe− /− controls (Fig. 3B and 
Supplementary Table 2). Quantitative PCR analysis confirmed that Akt 
mRNA levels were significantly increased in murine aortas from 
Apoe− /− /Neil3− /− as compared to Apoe− /− mice (Fig. 5A). We also 
observed increased Akt phosphorylation in western blots of explant 
aortic VSMCs and whole aorta from Apoe− /− /Neil3− /− mice as compared 
to Apoe− /− mice (Fig. 5B and C). In addition, the increased proliferation 
and lipid uptake in NEIL3-deficient HaoVSMCs was strongly reversed by 
addition of an AKT inhibitor (Fig. 5D). These findings combined suggest 
the Akt signaling pathway as a novel target for NEIL3-regulated control 
of VSMC functions. 
4. Discussion 
NEIL3/Neil3 is a DNA glycosylase initiating repair of oxidized DNA 
bases which functions in the maintenance of genomic stability of ver-
tebrates [28,29]. In the present study, we show that Neil3 deficiency in 
Apoe− /− mice on chow diet markedly increased plaque development in 
the aortic root without affecting the systemic lipid and cytokine profile. 
We demonstrate that increased plaque development in 
Apoe− /− /Neil3− /− mice was associated with a shift in VSMC phenotype 
towards a proliferating, lipid-accumulating and secretory 
macrophage-like cell phenotype. Plaque area was however not signifi-
cantly different in the aortic arch, when comparing the two genotypes. 
The aortic root is often the first area in the aorta to develop athero-
sclerosis in murine models, indicating that Neil3 deficiency could be 
more essential in the initiation steps of atherogenesis [30]. Further, it 
could be that the VSMC phenotype observed in our model is most 
Fig. 2. NEIL3-deficient human aortic VSMC (HaoVSMC) show phenotypic modulation with increased proliferation and lipid uptake. 
(A) NEIL3-deficient HaoVSMC positive for BrdU proliferation marker compared to controls (n = 5). Data presented as average from three pooled independent 
experiments. (B) mRNA expression levels of ACTA2, CD68, TGFβ, PAI-1, and MMP-2 (n = 4). (C) MMP-2 secretion in NEIL3 deficient-HaoVSMC (n = 4). (D) Tri-
glycerides and total cholesterol uptake in NEIL3 deficient-HaoVSMC (n = 6). (E) Quantification and representative pictures of lipid loading co-staining with Dil- 
OxLDL and DAPI in NEIL3-deficient HaoVSMC and controls. Data presented as mean and SD. T-test *p < 0.05, **p < 0.01, ***p < 0.001. ns, not statistically sig-
nificant. KD, knock-down; NT Ctrl, non-treatment control; rlu/s, relative light units per second. 
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important for the initiation of atherosclerosis, and not for its progres-
sion, and plaque development in the aortic arch (later stage of 
atherogenesis). 
Several studies have pinpointed the remarkable plasticity of VSMCs 
in the vessel wall, where VSMCs undergo complex structural and func-
tional changes during atherosclerosis development [31]. Herein, 
Apoe− /− /Neil3− /− aortic roots presented increased media thickness and 
media area percentage to total plaque area compared to controls, with 
remarkably no changes in ACTA2, the traditional marker for VSMCs. In 
fact, in the last years it has become clear that correct identification of 
VSMCs poses a challenge, since VSMCs can undergo phenotypic 
switching from an anti-atherogenic to a pro-atherogenic lesional cell 
phenotype where the traditional contractile VSMC markers, e.g., Acta2, 
are downregulated, and classical markers of macrophages, e.g., Cd68, 
are upregulated [31]. Indeed, we showed that knock-down of NEIL3 in 
human aortic VSMCs induced upregulation of CD68, TGF-β, PAI-1 and 
MMP-2, but not ACTA2. Importantly, this phenotypic switch was also 
seen at the functional level as NEIL3 deficiency induced increased pro-
liferation and lipid accumulation as well as boosted secretory capacity 
(i.e., MMP-2) in human aortic VSMCs. Moreover, in Apoe− /− mice we 
found that Neil3 was expressed in a small number of lineage-traced 
plaque VSMCs within the expression domain of the progenitor marker 
Ly6a/Sca-1. Indeed, Sca1+ progenitor cells have been found in the 
adventitia proximal to atherosclerotic lesions where they differentiate 
into pro-atherogenic Acta2-negative VSMCs [32]. 
A growing number of studies support a possible distinct function of 
NEIL3/Neil3 beyond canonical DNA repair. Recent work has demon-
strated that Neil3 is involved in the regulation of cardiac fibroblast 
proliferation in Neil3-deficient mice following MI [8]. Moreover, Neil3 
has been shown to affect the proliferation of murine embryonic fibro-
blasts in an in vitro system [12,33]. The present findings suggest that 
Neil3 can also regulate VSMC proliferation and transdifferentiation, 
thereby affecting the susceptibility to develop atherosclerosis. Taken 
together, these findings raise the possibility of Neil3 being an important 
regulator or switch of fibrogenesis and extracellular matrix through 
non-canonical mechanisms. Most importantly, regulation of fibrosis is of 
outmost significance not only in atherosclerosis and other cardiovas-
cular diseases, but also in several other inflammatory disorders. In our 
opinion, therapy targeting NEIL3 could be of interest in future studies on 
these disorders. 
Our results show that lack of Neil3/NEIL3 promotes atherosclerosis, 
possibly driven by VSMC proliferation and phenotypic switching. 
However, the proliferative phenotype was not explained by insults to 
genomic DNA in Apoe− /− /Neil3− /− mice. To elucidate the molecular 
cause of our observations we performed mRNA-seq of aortic VSMCs 
from both murine and human models. These analyses showed that 
VSMCs lacking Neil3 were enriched in genes associated with extracel-
lular structure organization/adhesion, proliferation, differentiation and 
development, as well as responses to growth factors, cytokines and stress 
stimuli. Furthermore, proteomic analysis of human aortic VSMCs lack-
ing NEIL3 revealed regulation of proteins involved in cell proliferation, 
survival, and phenotypic modulation. One striking finding in our RNA- 
seq data analysis was the ubiquity of one of the gene hits, the RAC- 
alpha serine/threonine-protein kinase Akt1/PKB. In fact, Akt1 has 
been previously seen to influence the migratory and survival capabilities 
of VSMCs in the context of cardiac dysfunction and plaque stability in 
atherosclerosis [26]. Akt signaling has also been shown to promote 
phenotypic switching in aortic VSMCs from a contractile to synthetic 
phenotype [34]. We showed that AKT inhibition strongly counteracted 
proliferation in NEIL3-abrogated primary human aortic VSMCs. Our 
data suggest that NEIL3 deficiency promotes VSMC proliferation and 
potentially also atherogenesis through activation of the Akt signaling 
Fig. 3. RNA-sequencing analysis confirms phenotypic modulation in aortic VSMC from Apoe− /− /Neil3− /− mice. 
(A) Enriched Gene Ontology (GO) biological processes in gene hits from RNA sequencing of aortic VSMC of Apoe− /− /Neil3− /− mice. GO terms in red represent Akt1 
gene hits. Clusters comprehend GO subcategories as nodes colored by p-value with edge thickness representing Cosine similarity between nodes. (B) Top 25 beta- 
values (natural-log fold change) of differentially expressed genes (DEGs), in order of statistical significance, from aortic VSMC RNA sequencing of Apoe− /− /Neil3− /−
versus Apoe− /− mice. Red bar and arrow highlight Akt1 hit. DEGs p < 0.001. v. stands for transcript version. (For interpretation of the references to color in this figure 
legend, the reader is referred to the Web version of this article.) 
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pathway. 
We have previously shown that NEIL3 expression was increased in 
human carotid plaques, and that Neil3 deficiency increased suscepti-
bility to develop atherosclerosis in Apoe− /− mice fed a high fat diet 
potentially involving altered macrophage function [11]. In the present 
study, we show that Apoe− /− /Neil3− /− mice fed a regular diet also 
developed enhanced atherosclerosis and, in contrast to high fat diet-fed 
mice, plaque development appears to be caused by transdifferentiated 
VSMCs without any alterations in circulating lipids or plaque macro-
phage accumulation. The reason for these diet-dependent differences on 
Neil3 deficiency in Apoe− /− is at present not clear, but it could reflect the 
importance of metabolic stress on phenotype development, despite 
similar genotype. 
The present study has some limitations such as the lack of quanti-
tative analysis of lipid accumulation in VSMC in vivo, and the effect of 
Akt inhibition on a more thorough characterization of the VSMC 
phenotype. Moreover, our results on transdifferentiated VSMC charac-
terization are to some extend limited due to the lack of analysis to 
thoroughly characterize the VSMC phenotype. VSMC plasticity is highly 
dependent on disease context and degree of disease [31], which makes a 
comprehensive understanding of their nature difficult to study. Further 
studies using targeted NEIL3/Neil3 knock-out in VSMCs, as well as VSMC 
lineage-tracing models and extensive single cell-RNA sequencing, could 
uncover the precise impact of NEIL3/Neil3 deficiency in VSMC and its 
role in atherosclerosis. In addition, the HaoVSMCs in this study were not 
a total knock-out of NEIL3, since we achieved between 70 and 80% 
knock-down, which has to be considered for final interpretations. 
Moreover, the lack of available Neil3 antibodies makes functional and 
targeted analysis of Neil3 regulation and function challenging, as tran-
scription is the only assessment to address Neil3 expression to date. 
Finally, and most importantly, the exact molecular mechanisms by 
which Neil3 modulates atherogenesis and VSMC in particular are still 
unknown. 
In summary, our results suggest that NEIL3/Neil3 is a novel player in 
the regulation of VSMC biology, controlling cell proliferation and dif-
ferentiation, including structural and migratory functions. Lack of Neil3 
in atherosclerosis-prone mice promotes a pro-atherogenic macrophage- 
like lesional VSMC phenotype through non-canonical mechanisms that 
involves regulation of the Akt signaling pathway, possibly exacerbating 
atherosclerosis in our model. 
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A. Quiles-Jiménez et al.                                                                                                                                                                                                                        
